Eidelman Virant Capital Teva Pharmaceutical Industries LTD Transaction History
Eidelman Virant Capital
- $136 Million
- Q3 2022
A detailed history of Eidelman Virant Capital transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Eidelman Virant Capital holds 46,718 shares of TEVA stock, worth $759,167. This represents 0.28% of its overall portfolio holdings.
Number of Shares
46,718
Previous 46,718
-0.0%
Holding current value
$759,167
Previous $329,000
15.5%
% of portfolio
0.28%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
539Shares Held
548MCall Options Held
19.8MPut Options Held
14M-
Black Rock Inc. New York, NY43.7MShares$710 Million0.01% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.6MShares$627 Million36.28% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L334.6MShares$562 Million7.05% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.9MShares$485 Million6.74% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L328.8MShares$468 Million4.57% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...